Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Theralink Technologies
(OTCPK:THER)
Intraday
$0.001
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.001
0
[0.00%]
At close: Apr 29
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Theralink Technologies Stock (OTC:THER)
Theralink Technologies Stock (OTC: THER)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 13, 2023
Theralink And IMAC Holdings Announce Receipt And Response To The Securities And Exchange Commission Comments On The Previously Filed Form S4; Co's Expect To Hear Back From The Securities And Exchange Commission Within The Next 10 Business Days
Benzinga Newsdesk
-
Nov 13, 2023, 3:06PM
Tuesday, May 23, 2023
Theralink Signs Definitive Merger Agreement To Be Acquired By IMAC Holdings; No Terms Disclosed
Benzinga Newsdesk
-
May 23, 2023, 8:32AM
Monday, January 21, 2013
Theratechnologies Announces FDA Approves SNDA for Alternative Storage Conditions for EGRIFTA
Benzinga
-
Jan 21, 2013, 7:01AM
Thursday, September 27, 2012
Stocks Hitting 52-Week Lows
Benzinga
-
Sep 27, 2012, 10:15AM
Monday, June 25, 2012
Winning Trades Based on Analyst Ratings for June 25
Benzinga
-
Jun 25, 2012, 1:42PM
UPDATE: Bloom Burton Downgrades Theratechnologies to Sell, Lowers PT
Benzinga
-
Jun 25, 2012, 9:43AM
Bloom Burton & Co. Downgrades Theratechnologies from Hold to Sell, Lowers PT to $0.75
Benzinga
-
Jun 25, 2012, 7:42AM
Friday, June 22, 2012
Theratechnologies Down 57% on Tesamorelin Non-Compliance Notice
Benzinga
-
Jun 22, 2012, 12:45PM
Mid-Day Market Losers
Benzinga
-
Jun 22, 2012, 12:06PM
Tuesday, February 21, 2012
Theratechnologies Announces a Supply, Distribution and Licensing Agreement With Actelion Pharmaceuticals Canada
Benzinga
-
Feb 21, 2012, 7:33AM
Wednesday, December 07, 2011
PREVIEW:Theratechnolgies to Resume Trading at 9am
Benzinga
-
Dec 7, 2011, 8:35AM
Theratechnolgies Halted; Pending News
Benzinga
-
Dec 7, 2011, 8:30AM
Wednesday, October 19, 2011
Theratechnologies Announces Application for Registration of Tesamorelin in Mexico
Benzinga
-
Oct 19, 2011, 9:23AM
Tuesday, September 06, 2011
Theratechnologies Launches Phase 2 Clinical Trial to Investigate Tesamorelin for the Treatment of COPD-Associated Muscle Wasting
Benzinga
-
Sep 6, 2011, 9:32AM
Tuesday, July 19, 2011
Theratechnologies: Results of Independent Study on the Effect of Tesamorelin on Cognitive Function Presented at Conference in France
Benzinga
-
Jul 19, 2011, 11:03AM
Thursday, July 07, 2011
Theratechnologies Expects 2011 US EGRIFTA Sales $25-30M; Cuts 25% of Workforce
Benzinga
-
Jul 7, 2011, 7:10AM
Tuesday, July 05, 2011
Theratechnologies Announces the Filing of an Application for Registration of Tesamorelin in Israel by Sanofi
Benzinga
-
Jul 5, 2011, 12:48PM
